JILLIAN JOHNSON: Open Payments
NPI 1023612843 · TEMPLETON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,527 in 88 payments from 17 companies in 2025. Trend: 2023 $2,750 · 2024 $2,358 · 2025 $2,527
Food & beverage: $2,517Education: $10
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $345 |
| Lilly USA, LLC | 8 | $325 |
| ABBVIE INC. | 15 | $278 |
| Incyte Corporation | 19 | $258 |
| Galderma Laboratories, L.P. | 4 | $187 |
| GENZYME CORPORATION | 2 | $181 |
| Regeneron Healthcare Solutions, Inc. | 3 | $166 |
| Arcutis Biotherapeutics, Inc. | 6 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $144 |
| Organogenesis Inc. | 1 | $140 |
Products named: DUPIXENT, CIBINQO, OPZELURA, SKYRIZI, TALTZ, TREMFYA, Zoryve, NOVACHOR.
Industry payments across CA — which companies pay providers there.
